Evidence map›Paper›PMID 42005539›Full record

ArticleCurrent research in microbial sciences2026

One-year multicenter surveillance of Fosfomycin resistance Enterobacterales: the rise of FosA3-producing

Katerina Chudejova, Vittoria Mattioni Marchetti, Vita Zaccaria, Stepanka Kanova, Anna Sramkova, Marcela Krutova, Lenka Ryskova, Gabriela Kroneislova, Beata Horvathova, Renata Tejkalova and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current research in microbial sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Katerina ChudejovaDepartment of Microbiology, Faculty of Medicine, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
Vittoria Mattioni MarchettiScienze Clinico, Chirurgiche, Diagnostiche, Pediatriche Department, Microbiology Unit, University of Pavia, Pavia, Italy.
Vita ZaccariaMicrobiology and Virology Unit, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy.
Stepanka KanovaUniversity of Chemistry and Technology Prague, Czech Republic.
Anna SramkovaDepartment of Microbiology, Faculty of Medicine, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
Marcela KrutovaDepartment of Medical Microbiology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Lenka RyskovaDepartment of Clinical Microbiology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
Gabriela KroneislovaDepartment of Clinical Microbiology and ATB Centre, Institute of Medical Biochemistry and Laboratory Diagnostic, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Beata HorvathovaDivision of Clinical Microbiology and Immunology, Department of Laboratory Medicine, University Hospital Brno, Brno, Czech Republic.
Renata TejkalovaDepartment of Microbiology, St. Anne's University Hospital, Brno, Czech Republic.
Eva KrejciInstitute of Laboratory Medicine, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
Iva VagnerovaDepartment of Microbiology, Faculty of Medicine, Palacky University, University Hospital Olomouc, Olomouc, Czech Republic.
Zuzana ZemanovaClinical Microbiology and ATB Centre, Na Homolce Hospital, Prague, Czech Republic.
Ibrahim BitarDepartment of Microbiology, Faculty of Medicine, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global rise of antimicrobial resistance has renewed interest in fosfomycin (FOS), an old antibiotic with activity against multidrug-resistant

Indexed as

Escherichia coliFosfomycinNational epidemiologyPlasmid-mediated fosA-like genesProteus mirabilisWhole-genome sequencing

Identifiers

PMID42005539
PMCPMC13084946

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.